We are live on ! Find out more
ACOR

Acorda Therapeutics
ACOR

Delisted

ACOR was delisted on the 11th of April, 2024.

Back to rankings

175 hedge funds and large institutions have $899M invested in Acorda Therapeutics in 2016 Q4 according to their latest regulatory filings, with 28 funds opening new positions, 59 increasing their positions, 57 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed

56% more first-time investments, than exits

New positions opened: 28 | Existing positions closed: 18

5% more funds holding

Funds holding: 167 → 175 (+8)

4% more repeat investments, than reductions

Existing positions increased: 59 | Existing positions reduced: 57

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

11% less capital invested

Capital invested by funds: $1.01B → $899M (-$108M)

83% less call options, than puts

Call options by funds: $7.01M | Put options by funds: $40.8M

Holders
175
Holders Change
+8
Holders Change %
+4.79%
% of All Funds
4.38%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
28
Increased
59
Reduced
57
Closed
18
Calls
$7.01M
Puts
$40.8M
Net Calls
-$33.8M
Net Calls Change
-$26.8M

Top Buyers

Rank Fund Capital Flow
1
PA
Perceptive Advisors
New York
+$14.3M
2
BFA
BlackRock Fund Advisors
California
+$12.4M
3
SCM
Scopia Capital Management
New York
+$6.5M
4
SM
Sabby Management
Florida
+$5.23M
5
Millennium Management
Millennium Management
New York
+$4.83M

Top Sellers

Rank Fund Capital Flow
1
EAM
Eagle Asset Management
Florida
-$13.7M
2
Citadel Advisors
Citadel Advisors
Florida
-$10.8M
3
Wellington Management Group
Wellington Management Group
Massachusetts
-$8.44M
4
Goldman Sachs
Goldman Sachs
New York
-$7.54M
5
Westfield Capital Management
Westfield Capital Management
Massachusetts
-$7.43M
Name Holding Trade Value Shares
Change 		Change in
Stake
PFBT
176
Parkside Financial Bank & Trust
Missouri
$1K – – –
YWP
177
YorkBridge Wealth Partners
New York
$1K – – –
QCG
178
Quadrant Capital Group
Ohio
$1K +$2.38K +1 New
Westfield Capital Management
179
Westfield Capital Management
Massachusetts
– -$7.43M -2,966 Closed
SAM
180
Senzar Asset Management
New York
– -$4M -1,596 Closed
DM
181
Deerfield Management
New York
– -$3.37M -1,346 Closed
SFM
182
Sphera Funds Management
Israel
– -$3.09M -1,233 Closed
Point72 Asset Management
183
Point72 Asset Management
Connecticut
– -$2.32M -926 Closed
Arrowstreet Capital
184
Arrowstreet Capital
Massachusetts
– -$656K -262 Closed
SSA
185
Schonfeld Strategic Advisors
New York
– -$613K -245 Closed
CG
186
Clinton Group
New York
– -$532K -213 Closed
EAM
187
EverPoint Asset Management
Connecticut
– -$522K -208 Closed
GCP
188
GSA Capital Partners
United Kingdom
– -$463K -185 Closed
SCA
189
Secor Capital Advisors
New York
– -$274K -110 Closed
AG
190
Aperio Group
California
– -$262K -105 Closed
CA
191
Corrado Advisors
New Jersey
– -$221K -88 Closed
Ohio Public Employees Retirement System (OPERS)
192
Ohio Public Employees Retirement System (OPERS)
Ohio
– -$74K -30 Closed
BJ
193
BlackRock Japan
Japan
– -$10K -4 Closed
ACH
194
ArrowMark Colorado Holdings
Colorado
– -$2K -1 Closed
HR
195
Howe & Rusling
New York
– -$2K -1 Closed
IA
196
IFP Advisors
Florida
– -$2.38K -1 Closed
VCM
197
Versant Capital Management
Arizona
– -$1K – –
4 5 6 7
8

ACOR Hedge Fund Activity: Q4 2016 in Review

175 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in Acorda Therapeutics (ACOR) for Q4 2016, worth a combined $899M — down 11% from $1.01B a quarter earlier.

Buyers outnumbered sellers: 28 funds opened new ACOR positions and 18 closed out — a net gain of 10 holders — while 59 added to existing stakes and 57 trimmed.

The largest buyer was Perceptive Advisors, opening a new position worth an estimated $14.3M. The largest seller was Eagle Asset Management, cutting an estimated $13.7M.

  • 175 institutional investors held Acorda Therapeutics (ACOR) as of Q4 2016, up from 167 in Q3 2016.
  • Funds reported $899M of Acorda Therapeutics stock for Q4 2016, down 11% quarter-over-quarter.
  • 28 funds opened new Acorda Therapeutics positions in Q4 2016 and 18 closed out, a net change of +10 holders.
  • The largest Acorda Therapeutics buyer in Q4 2016 was Perceptive Advisors, an estimated $14.3M added.
  • The largest Acorda Therapeutics seller in Q4 2016 was Eagle Asset Management, an estimated $13.7M sold.

Based on aggregated 13F filings for Q4 2016.